93% of patients with HMR had a reduction in whole blood mutCALR VAF, as did 88% of those without HMR mutations. A reduction in mutCALR-positive hematopoietic stem and progenitor cells (HSPCs) was also ...
PF1007 PS2082 The Phase 2 EPCORE DLBCL-3 study (abstract PS2082 ) evaluated the efficacy and safety of fixed-duration epcoritamab monotherapy in newly diagnosed CD20+ large B-cell lymphoma (LBCL) ...
This is the repository for the LinkedIn Learning course HTML, CSS, and JavaScript: Building the Web. The full course is available from LinkedIn Learning. With over five billion global internet users ...
Gold and silver ETFs gained sharply on Friday as precious metal prices rall... NFO Alert: ICICI Prudential Mutual Fund launches Nifty Smallcap 250 ETF ICICI Prudential Mutual Fund has launched the ...